Last update:
Infectious diseases news
Mosquito nets remain a powerful weapon against malaria—but research warns their long-term effectiveness is under threat
A major analysis of 25 studies across Africa and Asia finds that insecticide-treated nets cut malaria cases by up to 68%—but highlights challenges that threaten to undermine their long-term impact.
3 hours ago
0
0
Why women with HIV are still dying early, even when virus is not main cause
Women with HIV most often die from preventable, trauma-related conditions like substance use and mental illness—not the virus itself. Yet these leading causes are largely missing from official death records, according to ...
Jun 13, 2026
0
5
A higher-dose flu shot could spare millions of older adults a hospital stay
Influenza is a seasonal condition that causes coughing, sneezing, mild fever and aches in most cases. However, it can sometimes take a serious turn, leading to hospitalization, especially for young children, adults over 65 ...
Brain-like organoids reveal how Ebola persists and spreads for 120 days
Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. The danger is that those affected may ...
Jun 12, 2026
0
15
Scientists track single-dose vaccines for Andes hantavirus strain
In a study published in The Lancet, researchers at The University of Texas Medical Branch (UTMB) report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus ...
Jun 12, 2026
0
7
Flu infection may weaken tuberculosis defenses by disrupting key immune pathways
New research from Imperial College London suggests that infection with the influenza virus may leave people more susceptible to tuberculosis. The findings suggest that seasonal flu vaccines could offer a potential new strategy ...
Jun 12, 2026
0
4
Severe COVID-19 reveals distinct immune patterns tied to metabolism, not just antiviral response
Patients with COVID-19 can show several different antiviral immune response patterns, which may influence how the disease develops. This is shown in a new study from Karolinska Institutet, published in Genome Medicine, highlighting ...
Jun 12, 2026
0
6
Q&A: The dismantling of US global aid is a cascading crisis, say experts
The 2025 executive order dismantling U.S. Agency for International Development programs canceled 90% of the agency's contracts and grants, destabilizing health systems globally.
Jun 12, 2026
0
3
Blood antibody levels could clarify long COVID prognosis and memory problems
Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined. Long COVID (LC) can cause fatigue, headaches, sleep disturbances, breathing ...
Jun 12, 2026
0
9
Ebola spreading into new areas in northeast DR Congo: WHO
The Ebola outbreak in the northeastern Democratic Republic of Congo is spreading into new areas, the World Health Organization warned Friday.
Jun 12, 2026
0
4
Health 'war room,' digital tools are tracking disease risks during World Cup
With 48 teams competing across 16 host cities in the U.S., Canada and Mexico, tracking the health and location of World Cup players and fans is a logistical challenge that public health experts want to get a handle on.
Jun 12, 2026
0
4
Could the World Cup cause the next pandemic? Scientists mapped the risks
Spread across 11 U.S. host cities, the 2026 World Cup is bringing together teams and fans from 48 countries. From travel logistics to accommodations for hundreds of thousands of visitors, organizers are addressing a host ...
Jun 12, 2026
0
3
Chlamydia vaccine push gets blueprint as key membrane protein structure emerges
Scientists at UT Southwestern Medical Center, working with other U.S. researchers, have uncovered the structure of a key cell membrane protein in a bacterial model for Chlamydia trachomatis, the cause of the world's most ...
Jun 11, 2026
0
4
New study shows metformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long COVID by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced ...
Jun 11, 2026
0
56
Remote monitoring alone fails to reduce readmissions for sepsis, trial finds
Remote monitoring isn't a panacea for reducing readmissions across all conditions—and for some patients, clinicians should proceed with caution, clinical trial results published in JAMA Network Open suggest.
Jun 11, 2026
0
2
Is the Ebola quarantine in the US legal? Expert weighs in
Countries across the globe are on high alert as health workers race to contain an outbreak of the Ebola virus in Central and East Africa that has killed more than 100 people and infected almost 570, according to data from ...
Jun 11, 2026
0
5
OB-GYN group makes vaccine recommendations for the first time
A prominent OB-GYN group announced vaccine recommendations on Wednesday that differ from what the U.S. government advises.
Jun 11, 2026
0
4
How a louse-borne pathogen evades the immune system
Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice). The disease was first described by Hippocrates (460–370 B.C.). Initial symptoms include ...
Jun 10, 2026
0
3
Researchers identify which eye infections pose greatest threat to vision
Eye surgery today is safer than ever, yet ophthalmologists must remain watchful for a rare but serious complication that can threaten sight within days: a bacterial eye infection called endophthalmitis. Now, clinician-scientists ...
Jun 10, 2026
0
2
New Lassa fever vaccine shows promising results for first-in-human clinical trial
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health, or CVD, report encouraging results from an early clinical trial that tested a new dual vaccine against Lassa ...
Jun 9, 2026
0
7
Brushing your teeth in hospital could reduce the chance of catching pneumonia
You go to the hospital for treatment and to get better. But sometimes, you get something much less welcome: an infection.
Jun 9, 2026
0
7
FDA approves Xocova for COVID-19 postexposure prophylaxis
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
Jun 9, 2026
0
16
World's first AI‑designed vaccine explained
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was designed entirely by AI and has now been ...
Jun 9, 2026
0
4
Tiny molecular fix revived tuberculosis antibiotic candidate and led to two patents
How can we combat the growing global health crisis of antibiotic resistance? At Leiden University, researchers are tackling this issue from multiple angles. Ph.D. candidate Vladyslav Lysenko develops and redesigns new antibiotic ...
Jun 9, 2026
0
3
Study looks at barriers to initiation of rotavirus vaccine
Risk factors for not initiating a rotavirus vaccine (RVV)—for which the first dose is recommended by a maximum age of 14 weeks, six days—include extremely preterm birth and having no health insurance, according to a study ...
Jun 9, 2026
0
3
